Scripps Research Identifies STING Protein as Driver of Brain Inflammation in Alzheimer's
Scientists at Scripps Research have identified the STING protein as a molecular switch that drives damaging brain inflammation in Alzheimer's disease. Separate research suggests CBD may help calm the brain's immune response, and a Texas A&M team has developed a nasal spray that appears to reverse brain aging in early animal testing.
Researchers at Scripps Research have identified the STING protein as a molecular switch that fuels damaging brain inflammation in Alzheimer's disease, a finding that could point toward new treatment targets.
The STING protein is part of the body's innate immune system. In Alzheimer's patients, researchers found that STING activation in the brain drives a chronic inflammatory response that damages neurons. Blocking this pathway in laboratory models reduced inflammation and slowed disease progression.
Separate research published in early June 2026 suggests that CBD may help mitigate Alzheimer's progression by calming the brain's immune response. The studies add to a growing body of evidence that neuroinflammation, not just amyloid plaques, plays a central role in the disease.
A team at Texas A&M has developed a nasal spray that appears to reverse brain aging and improve cognitive function in early animal testing. The spray delivers compounds directly to the brain through the nasal passage, bypassing the blood-brain barrier. Human trials have not yet begun.
Other research published around the same time found that protein traffic jams in cellular machinery contribute to age-related cognitive decline. When proteins cannot move efficiently through cells, they accumulate and disrupt normal brain function.
A brain imaging study found no evidence of widespread brain inflammation in patients with long COVID, contrary to previous hypotheses. Instead, the study pointed to altered activity in brain regions associated with mood, suggesting that long COVID's cognitive symptoms may have a different mechanism than initially thought.
Alzheimer's cases in the United States have reached 7.4 million in 2026, according to recent estimates. Experts continue to emphasize that midlife is the most important window for prevention, with lifestyle factors including exercise, sleep, and diet playing significant roles in reducing risk.
